| Development and description of GETT: a genetic testing evidence tracking tool. | |
| | |
MedLine Citation:
|
PMID: 20658948 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
BACKGROUND: The completion of the Human Genome Project has increased the pace of discovery of genetic markers for disease. Despite tremendous efforts in fundamental research, clinical applications still lag behind expectations, partly due to the lack of effective tools to systematically search for and summarize published data relative to the clinical assessment of new diagnostic molecular tests. METHODS: Through a collaborative process using published tools and an expert panel, we developed a detailed checklist of the evidence that needs to be collected or produced to evaluate the potential usefulness of a new molecular diagnostic test. This tool is called GETT, for Genetic testing Evidence Tracking Tool. RESULTS: GETT allows 1) researchers to summarize the current evidence and to identify knowledge gaps for further research and; 2) stakeholders to collect data related to a given molecular test and improve their decision-making process. GETT comprises 72 clearly defined items/questions, grouped into 10 categories and 26 sub-themes, including an overview of disease epidemiology and genetics, the available diagnostic tools, and their analytical and clinical performances, availability of quality control programs, laboratory and clinical best practice guidelines, clinical utility, and impact on health care and psycho-social, ethical and legal implications. It also includes a summary of the evidence available and attempts to prioritise knowledge gaps related to the testing. We also compare GETT to other existing frameworks. CONCLUSIONS: This systematic evidence-based tracking tool, which is more detailed than existing frameworks and provides clear definition for each item, will help streamline collection of the available evidence to appraise the potential for clinical application of new molecular diagnostic tests and prioritize research to produce the evidence-base relative to the clinical implementation of molecular diagnostic tests. |
| | |
Authors:
|
François Rousseau; Carmen Lindsay; Marc Charland; Yves Labelle; Jean Bergeron; Ingeborg Blancquaert; Robert Delage; Brian Gilfix; Michel Miron; Grant A Mitchell; Luc Oligny; Mario Pazzagli; Cyril Mamotte; Deborah Payne; |
Related Documents
:
|
17044338 - Genetic testing, genetic information, and the role of maternal-child health nurses in i... 19817648 - Considerations for the development of a reference method for sequencing of haploid dna-... 20659598 - Prenatal and postnatal diagnosis of 22q11.2 deletion syndrome. 16178398 - Inheritance of recurrent exertional rhabdomyolysis in thoroughbreds. 11476438 - Detection of giardia lamblia and entamoeba histolytica in stool samples by two enzyme i... 7817678 - Nickel patch test reactivity and the menstrual cycle. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-07-27 |
Journal Detail:
|
Title: Clinical chemistry and laboratory medicine : CCLM / FESCC Volume: 48 ISSN: 1434-6621 ISO Abbreviation: Clin. Chem. Lab. Med. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9806306 Medline TA: Clin Chem Lab Med Country: Germany |
Other Details:
|
Languages: eng Pagination: 1397-407 Citation Subset: IM |
Affiliation:
|
Réseau de Médecine Génétique Appliquée du Fonds de Recherche en Santé du Québec, Québec, Canada. Francois.rousseau@mac.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Grant Support | |
ID/Acronym/Agency:
|
//Canadian Institutes of Health Research |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Strategies for successful clinical management of schizophrenia with ziprasidone.
Next Document: Lost in translation…wallowing in transformation?